Scarica l'app Stockscreener
2.95
0.67%
-0.02
Dopo l'orario di chiusura:
3.00
0.05
+1.69%
Precedente Chiudi:
$2.97
Aprire:
$3
Volume 24 ore:
84,090
Relative Volume:
0.01
Capitalizzazione di mercato:
$17.42M
Reddito:
-
Utile/perdita netta:
$-9.32M
Rapporto P/E:
-0.2321
EPS:
-12.7107
Flusso di cassa netto:
$-7.30M
1 W Prestazione:
-4.53%
1M Prestazione:
+3.87%
6M Prestazione:
+70.52%
1 anno Prestazione:
+3.51%
Intervallo 1D:
$2.85
$3.00
Intervallo di 1 settimana:
$2.85
$3.2099
Portata 52W:
$0.952
$9.08
Tharimmune Inc Stock (THAR) Company Profile
Nome
Tharimmune Inc
Settore
Industria
Telefono
302-743-2995
Indirizzo
1200 ROUTE 22 EAST, BRIDGEWATER
Confronta THAR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
2.95 | 22.60M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tharimmune Inc Borsa (THAR) Ultime notizie
What insider trading reveals about Tharimmune Inc. stockWeekly Market Outlook & Daily Price Action Insights - newser.com
Will Tharimmune Inc. stock sustain high P E ratios2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Does Tharimmune Inc. fit your quant trading model2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com
What the charts say about Tharimmune Inc. todayTrade Entry Report & Consistent Profit Alerts - newser.com
Using data models to predict Tharimmune Inc. stock movementMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
Will earnings trigger a reversal in Tharimmune Inc.Quarterly Investment Review & Safe Entry Trade Reports - newser.com
Will Tharimmune Inc. continue its uptrendWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Why analysts upgrade Tharimmune Inc. stock2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com
Is Tharimmune Inc. stock attractive for retirement portfoliosPortfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com
Is Tharimmune Inc. still worth holding after the dipOil Prices & Low Drawdown Investment Strategies - newser.com
Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments - Pueblo Chieftain
What analysts say about Tharimmune Inc stockSector-Based Investing & Maximize Returns With Insights - earlytimes.in
How resilient is Tharimmune Inc. stock in market downturns2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
Can Tharimmune Inc. stock continue upward trendQuarterly Growth Report & Reliable Breakout Forecasts - fcp.pa.gov.br
Tharimmune’s New Study on TH104: A Potential Game-Changer for PBC Treatment - TipRanks
Tharimmune, Inc.Common Stock (NQ: THAR - FinancialContent
Tharimmune Inc Azioni (THAR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):